{"id":"W2007900098","doi":"10.1053/j.ackd.2008.12.010","title":"Current and Upcoming Erythropoiesis-Stimulating Agents, Iron Products, and Other Novel Anemia Medications","year":2009,"lang":"en","type":"review","venue":"Advances in Chronic Kidney Disease","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Biosimilar; Medicine; Erythropoietin; Erythropoiesis; Anemia; Darbepoetin alfa; Dosing; Erythropoietin receptor; Pharmacology; Intensive care medicine; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004469403,0.0006601061,0.001614018,0.001672753,0.0002191859,0.0006073499,0.0007259813,0.0006336119,0.005300479],"category_scores_gemma":[0.0005128848,0.0002420329,0.0005193907,0.001587993,0.0002557274,0.0008390716,0.0003987786,0.001558789,0.002211627],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003257891,"about_ca_system_score_gemma":0.0007309563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00103144,"about_ca_topic_score_gemma":0.003001027,"domain_scores_codex":[0.999846,0.00001773732,0.00002424565,0.00002265442,0.00007631769,0.00001313846],"domain_scores_gemma":[0.9997365,0.0001267653,0.00004796448,0.000006615297,0.00005782852,0.00002441926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001351983,0.000136433,0.0001471068,0.008373224,0.0001013342,0.0001412769,0.00001995422,0.0001339677,0.001862466,0.0007474583,0.0249381,0.9632635],"study_design_scores_gemma":[0.0001238805,0.00022493,0.001999305,0.003056408,0.0003959347,0.001695916,0.00004566575,0.0001617925,0.001056507,0.001026398,0.9901929,0.00002041236],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002086763,0.9982053,0.0001420181,0.0001803526,0.0001681836,0.000008104254,0.00002666719,0.000009107011,0.001051578],"genre_scores_gemma":[0.0006850191,0.9972776,0.0004856387,0.0002309889,0.0002080555,0.000009433566,0.00006049439,0.000001470783,0.001041391],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005300479,"threshold_uncertainty_score":0.0177319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03730673176071105,"score_gpt":0.3794834466163756,"score_spread":0.3421767148556645,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}